Member Info for RayPointer

Https://www.sheffield.ac.uk/smph/people/clinical-medicine/sarah-danson

"I qualified in 1996 from the University of Nottingham and was a Specialist Registrar and Cancer Research UK Clinical Research Fellow in Pharmacology at the Christie Hospital, Manchester before moving to Sheffield in November 2006."

"My clinical and research interests are in the treatment of melanoma and lung cancer, and in the early clinical assessment of new anticancer agents. "

It's very possible that Sarah and Lindy are very well acquainted over a long period of time. One of Sarah's specialisms is in Melanoma, and she first qualified at Nottingham Uni and went on to work in Manchester.

C11, how dare you question Scinv's infallibility?

TG5

Simply because it is such an important milestone on the way to a substantial increase in JLP's copper production.

Ever since rat's post, I have this vision of Scinv, Knowlesi and Crackin all being in the same pram🤣

Surely an RNS should be issued once the Roan upgrade has been successfully commissioned.

1 cubic meter = 35.3 cubic feet so where do you get $2 per cubic foot?

Mushy pea cans are far more reliable

Good to hear from you C7. I hope you are well.

Meanwhile, it is good to see Scancell recruiting slaves to keep the wage bill down 😂

TF

"It's like not bothering to score until 'extra time'."

But if you already know that you are winning 3-0.

Whereas the crowd, being blindfolded, do not know the score.

The truth is that no-one knows when we will get the next update on the Scope trial.

That's exactly why Bermuda used the word "may" in his assessment.

I tend to agree with Konar and Burble.

In Konar's words:

"My gut feel.. FWIW, is that we are close enough to the full results now, that Scancell will be holding back for the full reveal when they have all the results in. Releasing more data at this stage just dilutes the impact. I think they are going headline grabbing in Q4."

It just feels like the correct strategy.

Spread the word as much as possible and then, when ready, publish updated results to gain maximum impact.

Lindy will already be in possession of updated data. If this data is disappointing, why continue with the strategy of spreading the word?

Scancell are still presenting either posters and/or talks on the other platforms. However, there is a definite bias towards the Scope trial in Scancell's recent posters/presentations at conferences. This bias continues with the ASCO conference.

😂

You will both miss the entertainment 😎

Hi TF

Just to clarify, I am with Scinv in that we do not know when new data is to be presented.

It may be prior or straight after the ASCO presentation or it may be at some other date.

I'm certainly not with Scinv on the statement "Bermuda is feeding you balls"

I think that CLX is a very interesting approach.

However, PM, where is the last RNS does it say that the early safety tests were fantastic?

This is what it does say:

"Testing is ongoing to assess the safety of the formulated product."

Very good news Kalan.

Long may it continue.

I actually agree with Scinv.

We will be updated on the Scope trial when Lindy is ready to update.

That may be when all patients have been recruited (43 patients) and it may be when Lindy feels there is enough scan data from a minimum number of patients.

But we are getting closer to an update

interesting ciaskin.

if my understanding is correct, snapvax is to be used instead of amplivant for modi-2.

https://www.scancell.co.uk/data/sites/1/media/publications/rns/scancell-in-licenses-vaccitech-technology-to-advance-modi-2-towards-the-clinic-final-07.11.22.pdf

"modi-2 will use snapvax™ to codeliver ****citrullinated peptide antigens

and tlr-7/8a adjuvants in self-assembling nanoparticles designed to prime tumour killing t cells. the

company expects that the combination of scancell’s modi-2 with a highly effective platform for inducing t cells

(vaccitech’s snapvax™ technology) will lead to a potentially superior therapeutic vaccine candidate."

It's good to see a balanced view between Porky Mark 1 and Porky Mark 2 😎

If a deal for 201 were in place then it might be a different matter